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Abstract
Introduction. Placement of the central vein catheterization (CVC) is a major risk factor for central vein stenosis (CVS). Repetitive endothelial
exposures to the CVC results in inflammation, microthrombi formation, hyperplasia of the intima, fibrosis and thus development of CVS. The
study aimed to find out the correlation between the duration and frequency of CVC in patients with CVS.
Method. A matched case-control study was conducted in dr. Cipto Mangunkusumo General Hospital. Samples were taken from the medical
record. Multivariate statistical comparisons were done using Chi-square tests.
Results. Fifty–four out of 717 patients underwent CVC for hemodialysis had CVS. A total of 32 patients with CVS enrolled in the study with 128
non–CVS patients as a control. Duration of CVC >6 weeks does not increase the risk of CVS (p = 0.207), whilst the odds ratio of CVS on the
frequency of CVC >2 times is 30 times compared to those underwent <2 times (p = <0.001).
Conclusion. The frequency of CVC >2 times increased the risk of CVS. Longer duration of CVC for hemodialysis did not increase CVS rate.
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Introduction

Method

Central venous catheter (CVC) for hemodialysis access is a major
factor in central venous stenosis. Clinical manifestation includes
upper limb and facial edema, collateral venous dilatation of the face,
neck, and chest, and ulceration and tissue damage.1–5 Schumacher et
al. (1989) reported the incidence of central venous stenosis in a
population of patients undergoing routine hemodialysis are 14%, 23–
29% in the US and Canada, whilst to date, remains no data in
Indonesia.6

A case-control design study conducted to determine the correlation
of duration and frequency of CVC as risk factors of CVS in dr. Cipto
Mangunkusumo General Hospital, Jakarta. Those with first inserted
short–term CVC between January 2013 to December 2015 were
included in the study. Meanwhile, those diagnosed with lymphoma
or bronchogenic carcinoma were excluded. Despite the subject’s
characteristics, the comorbid and sites of insertion were recorded, and
the occurrence of stenosis. Multivariate statistical comparisons using
Chi-square tests were done. Further multivariate logistic regression to
explore the risk ratio (RR) and the related 95% confidence intervals.
All statistical analysis was performed using SPSS for Windows Ver.
20 and p <0.001 was considered statistically significant.

Previous studies show predisposing factors for central venous
stenosis (CVS) after CVC placement for hemodialysis access
depends on the type of catheter (short term, long term, diameter),
duration of catheter use, and location of catheter placement
(subclavian vein, jugular vein). MacRae et al. (2005) showed the
prevalence of central venous stenosis by 41% in 133 patients with
hemodialysis catheter dysfunction.7 Repeated contact with blood
vessel walls can cause inflammation, muscle cell migration and
thrombus formation which can alter the flexibility of blood vessels
and increase blood vessel intraluminal pressure. The process resulted
in the occurrence of central venous stenosis.7 The aim of this study
was to investigate the correlation between duration and frequency of
CVC as risk factors for CVS.

Results
Out of 717 subjects underwent CVC placement for hemodialysis, a
total of 54 subjects were diagnosed with CVS. A matched casecontrol study was done on a total of 32 case subjects and 128 subjects
as control. Matching was based on age (>45 years) and gender
(males) with a ratio of 1:4.

Table 1. Incidence of central venous stenosis in dr. Cipto Mangunkusumo General Hospital
2013–2015
Variable
n
Percent
CVS
54
7.53
Non–CVS
663
92.7
Total
717
100
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Bivariate analysis was performed on the demographic characteristic
(Table 2). Diabetes mellitus was found in 5.5% of the non–CVC
subjects. Out of 32 CVS subjects, 30 had hypertension (93.7%) and
out of 128 non–CVS subjects, 108 had hypertension (84.3%). The
location of CVC placement in the subclavian vein has significantly
increased the risk for CVS (p <0.001).
Out of 50 subjects observed, 20 subjects had weight loss during the
observation. From 20 subjects who had hospital malnutrition, one

subject was from those who did not proceed to surgery, while the rest
were those who had undergone surgery. This hospital malnutrition
incidence was smaller compared to the previous research conducted
in 2007, in which the incidence was 52%. The characteristics of the
subjects with and without hospital malnutrition were compared in
table 2.

Table 2. Demographic characteristics of CVS patients in chronic kidney
disease patients with central venous access in dr. Cipto Mangunkusumo
General Hospital 2013–2015
Characteristics
Age group
− <45 years
− >45 years
Gender
− Male
− Female
Comorbid
− Diabetes
− Hypertension
Sites the CVC
− Subclavian vein
− Internal jugular vein
A multivariate analysis (binary logistic regression test) on the
duration and frequency of CVC as a predictor of CVS was
performed. CVS was found in 25 subjects (22.5%) on subjects with
a catheter duration >6 weeks and 7 subjects (13.7%) in subjects with
catheter duration <6 weeks. The analysis shows that catheter duration
is not statistically significant as a risk factor for CVS (p = 0.207) at

CVS n (%)

No CVS n (%)

p

–
32

–
128

32
–

128
–

0 (0%)
30 (93.7%)

7 (5.5%)
108 (84.3%)

0.102

28 (59.6%)
4 (3.5%)

19 (40.4%)
109 (96.5%)

<0.001

95% confidence level. A significant association was found between
the frequency of CVC insertion and CVS (p <0.001) at 95%
confidence level. Subjects underwent CVC insertion >2 times were
30 times compared to those underwent CVC <2 times (Table 3).

Table 3. Analysis of factors related to CVS occurrence in chronic kidney disease patients with CVC.
CVS (%)
No CVS %)
OR
CI 95%
Duration of catheter use
25(22.5%)
84 (77.5%)
1.9
0.8–4.7
− >6 weeks
7 (13.7%)
44 (86.3%)
− <6 weeks
Frequency of catheter insertion
− >2 times
− <2 times

28 (53.8%)
4 (4%)

The multi-regression analysis was done on the jugular vein
placement location and the frequency of CVC. It shows that both
variables are significantly related to CVS (p <0.001). The odds ratio
of jugular vein catheter placement was 81 and the odds ratio of the
frequency of catheter placement was 62.799 (Table 4). Meaning,
both variables are proven to be a significant risk factor for CVS.

Table 4. Multi regression analysis
CVS(%)
Frequency of
catheter placement
>2times

32
(20%)

No–
CVS(%)
128
(80%)

p
Value
<
0.001

OR (CI 95%)
62.799
(11.194 –
352.302)

24 (46.2%)
104 (96%)

30

9.7–94.6

p
0.207

<0.001

Discussion
Arteriovenous fistula has been the recommended access for long–
term hemodialysis because it provides the least complications
compared to arteriovenous graft and CVC. However, CVC as
hemodialysis access is unavoidable due to emergency access
required for the hemodialysis.1,8,14 It is important to minimize the use
of CVC through the construction of an arteriovenous fistula before
the chronic kidney disease continues to stage 5. Unfortunately, most
subjects in this study were those who came requiring emergency
hemodialysis.
CVS defined as stenosis or occlusion of the subclavian vein or
brachiocephalic vein or superior vena cava,20 interferes with the
hemodialysis circuit leading to venous hypertension and access flow

17

dysfunction and may result in loss of access.1,5,8 The CVS diagnosed
based on the symptoms and venographic findings. The most
common symptoms of CVS are swelling of the ipsilateral arm where
the CVC were placed, chest, neck and face.5,8–11 The prevalence of
CVS in this study is lower (7.53%) compared to the study in The
USA and Canada (23–29%). In our institution, all patients came with
severe symptoms.
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